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Abstract  1 
We devised an approach to extract control principles of cellular bioenergetics for intact and impaired 2 
mitochondria from ODE-based models and applied it to a recently established bioenergetic model of 3 
cancer cells. The approach used two methods for varying ODE model parameters to determine those 4 
model components that, either alone or in combination with other components, most decisively regulated 5 
bioenergetic state variables. We found that, while polarisation of the mitochondrial membrane potential 6 
(m) and, therefore, the protomotive force, were critically determined by respiratory complex I activity 7 
in healthy mitochondria, complex III activity was dominant for m during conditions of cytochrome-c 8 
deficiency. As a further important result, cellular bioenergetics in healthy, ATP-producing mitochondria 9 
was regulated by three parameter clusters that describe 1) mitochondrial respiration, 2) ATP production 10 
and consumption and 3) coupling of ATP-production and respiration. These parameter clusters resembled 11 
metabolic blocks and their intermediaries from top-down control analyses. However, parameter clusters 12 
changed significantly when cells changed from low to high ATP levels or when mitochondria were 13 
considered to be impaired by loss of cytochrome-c. This change suggests that the assumption of static 14 
metabolic blocks by conventional top-down control analyses is not valid under these conditions. Our 15 
approach is complementary to both ODE and top-down control analysis approaches and allows a better 16 
insight into cellular bioenergetics and its pathological alterations.  17 
 18 
19 
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Introduction 1 
Studying the mechanisms of cellular bioenergetics is essential to better understand cellular physiology 2 
and pathology. During the last century, several experimental and theoretical approaches provided a 3 
detailed picture of the basic physiological mechanisms of cellular ATP production and consumption 
1, 2
. 4 
More recently, the importance of cellular bioenergetic deregulations in several pathologies has become 5 
apparent. In cancer, cellular bioenergetics are altered to favour glycolysis over mitochondrial ATP 6 
production, making cancer cells better suited to cope with hypoxic conditions in solid tumours 
3
, and 7 
likely more resistant to therapeutically induced bioenergetic crises 
4-8
. In neurodegenerative diseases and 8 
ischemic stroke, alterations to the mitochondrial respiratory chain or impairment of mitochondrial ATP 9 
production are important hallmarks of the respective pathogeneses 
9-11
.  10 
Several approaches are available for studying cellular bioenergetics. Top-down control analyses 
12
 assume 11 
metabolic blocks (such as glycolysis, cytosolic ATP consumption, mitochondrial respiration and 12 
oxidative phosphorylation) and describe how these metabolic blocks interact by intermediary fluxes such 13 
as metabolite fluxes (ATP, NADH fluxes). Top-down control analyses abstract details of the underlying 14 
molecular mechanisms, and are therefore well suited to the study of large-scale networks such as 15 
mitochondrial and cytosolic ATP production/consumption 
12-15
. These approaches, however, are confined 16 
to near steady-state fluxes and may not be correct when fluxes are not in steady state equilibrium or when 17 
conditions change between mitochondria that produce ATP and those in a resting state. Likewise, the 18 
definitions of the metabolic blocks and their interactions may be arbitrary. While metabolic blocks are 19 
derived from bioenergetics in healthy physiology, it is not clear whether these blocks resemble cellular 20 
energetics in a pathological state such as when mitochondria are impaired. 21 
In contrast, mechanistic approaches based on ordinary differential equations (ODEs) integrate the detailed 22 
biophysical interplay of cellular and mitochondrial components such as respiratory complexes, molecular 23 
transporters, metabolites, ions and enzyme reactions 16-19. As they are based on molecular mechanisms, 24 
they are well suited to the study of a broad range of physiological and pathological situations, and the 25 
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transition between these states. They also allow the study of components and behaviour in conditions far 1 
from energetic equilibrium, as a function of time. As a drawback, the high level of detail of these models 2 
often occludes how bioenergetic components act together on a larger scale. Abstraction of concepts is 3 
necessary to build large-scale bioenergetic models that not only model mitochondrial and cytosolic ATP 4 
production, but also integrate signalling processes recently associated to cellular bioenergetic pathological 5 
alterations 
6, 20
.  6 
We present here an approach that abstracts regulatory principles from ODE-based models of cellular 7 
bioenergetics, and is flexible enough to be applied to situations where cellular bioenergetics change 8 
dramatically. We exemplify our approach by applying it to a model of mitochondrial bioenergetics 
16
 that 9 
we have recently calibrated to resemble bioenergetic data from in house, single-cell microscopy 10 
experiments 17 in HeLa cervical cancer cells. Our study is the first to demonstrate that ad hoc assumptions 11 
of (top down) metabolic control analyses, such as the assumption of three independent bioenergetic 12 
clusters, are justified by (bottom up) mechanistic principles, yet these clusters need to be adapted when 13 
energy levels or physiological conditions change to pathological situations. The study design and a result 14 
summary are given in Fig.1. 15 
 16 
Materials and Methods 17 
Model of mitochondrial bioenergetics  18 
We employed a model of the mitochondrial respiration chain and ATP production established by Beard 19 
which built upon works by Korzeniewski 
16, 18, 19, 21, 22
. We recently extended and calibrated the model to 20 
include parameters characterised in isolated mitochondria and successfully applied it to study 21 
mitochondrial bioenergetic recovery in HeLa cells following mitochondrial outer membrane 22 
permeabilisation 17. The model studies a set of bioenergetic state variables (Table I) in the mitochondrial 23 
matrix (4.5% of total cell volume), mitochondrial inter-membrane space (0.5% of total cell volume), and 24 
in the cytosol (95 % of total cell volume). State variable changes were mediated by bioenergetic flux 25 
5 
 
combinations (Table I, fourth column and Table II) and described by a set of ordinary differential 1 
equations (ODEs). The mitochondrial tricarbonic acid (TCA) cycle was not modelled explicitly. Instead, 2 
a substrate dehydrogenation process (NAD + H 
+
 → NADH +) was assumed to be present that drives the 3 
respiratory chain by supplying NADH. According to 
16
, this process was modelled by an input flux 4 
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which drives mitochondrial respiration by providing NADH. The constant rx was set to 45.9 in order to 6 
establish JDH by generating a NADH/NAD disequilibrium. The explicit dependency of JDH on ionic 7 
phosphate Pi in the matrix (index x) was also taken from 
16
 where it was introduced to resemble 8 
measurements of isolated mitochondria under varying phosphate buffer conditions. NADH produced by 9 
the flux in Eq. 1 was modelled to be subsequently consumed by complex I. Complex I activity drove 10 
complex III activity which in turn drove complex IV activity (Table II, components 2, 3 and 4). Each 11 
complex was assumed to pump protons from the matrix into the mitochondrial inter membrane space (4, 12 
4 and 2 protons for complexes I, III and IV, respectively). This established a proton gradient for ATP 13 
synthase. ATP synthase was modelled to synthesise ATP from ADP and phosphate, and to require Mg
2+
 14 
as a co-factor (defined together as component 5). ATP was provided by the adenosine nucleotide 15 
transferase (ANT, component 6). Constitutive proton leaks (component 7) were present as required for 16 
respiration in the absence of ATP production. The outer membrane was considered permeable for ADP, 17 
ATP, phosphate and protons (component 8). Phosphate/proton and potassium/proton exchangers 18 
(components 9 and 10) were considered to maintain ionic equilibrium and to provide phosphate for 19 
respiration.  20 
Cytosolic ATP levels were assumed to vary over time and were determined by mitochondrial ATP 21 
production (component 5) and by cytosolic ATP processes. The latter processes included cytosolic ATP 22 
production (i.e. by glycolysis) and ATP consumption (such as Na
+
/K
+
-ATPase activity and protein 23 
production). This separate treatment accounts for independent changes in the glycolytic rate, which may 24 
be caused by oncogenic signalling
17, 23, 24
, and for changes in ATP consumption which may, for instance, 25 
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result from a cellular signalling response to low energy
25
. Cytosolic ATP production was modelled to 1 
increase ATP concentration in proportion to the amount of available ADP (ADP -> ATP, flux Jprod ~ 2 
ADP). The speed of ATP consuming processes was assumed to be proportional to the levels of available 3 
ATP (ATP -> ADP, Jcons ~ ATP).  4 
Superposition of both effects leads to a flux 5 
)*(* ATPADPKxJJJ ATDPATPCconsprodATPC    .     Equation 2 6 
The free parameters KATDP and xATDP were adapted such that the flux in Equation 2 together with 7 
mitochondrial ATP production (component 5) renders a constant cytosolic ATP:ADP ratio of 100:1 or of 8 
3:1, assuming energetically saturated HeLa cells 
26
 or cells with reduced levels of ATP (KATDP = 30 or 2, 9 
xATDP = 0.0054 or 1.1,  for an ATP:ADP ratio of 100:1 and 3.1, respectively). We remark that according to 10 
the above assumptions mitochondrial ATP production alone would replenish ATP levels in intact 11 
mitochondria, while Eq. 2 drives the ATP:ADP ratio to a lower equilibrium. As a consequence, the 12 
cytosolic processes modelled in Eq. 2 always lead to a net consumption of mitochondrially generated 13 
ATP in cells with intact mitochondria. Likewise, since mitochondria still produce ATP when their cyt-c is 14 
depleted to 5%, Eq. 2 also describes a net consumption of mitochondrial ATP in such a case. Cytosolic 15 
ATP processes were therefore denoted as ‘cytosolic ATP consumption’ to better emphasise their ATP 16 
consuming role in these cases. Only in the case of cyt-c depletion to 0.5%, where no ATP is produced by 17 
mitochondria, do we retain the term ‘cytosolic ATP processes’ (for details on mitochondrial ATP 18 
production in all these cases, see 
17
). ATP and ADP levels in the other compartments (the mitochondrial 19 
matrix and inter membrane space) were established by a diffusion equilibrium with the external 20 
compartment. Consistent with 
16
, AMP was not studied explicitly. Cytosolic pH was assumed to be 7.4 to 21 
resemble cells in HEPES buffer. Matrix pH was set to 8.0 to resemble the pH-gradient between matrix 22 
and cytosol as detected by single cell imaging using pH dependent fluorescent proteins 
2, 27
. 23 
Cyt-c depletion was modelled as a consequence of cyt-c release following mitochondrial outer membrane 24 
permeabilisation (MOMP); a condition occurring during cellular injury and during chemotherapeutic 25 
treatment 28. Due to the subsequent re-equilibration of cyt-c between the cytosol and the mitochondrial 26 
7 
 
inter-membrane space a remnant fraction of cyt-c in the inter-membrane space is considered and two 1 
scenarios are assumed. In the first scenario, a tiny fraction of 0.5% cyt-c was assumed to remain in the 2 
mitochondrial inter-membrane space. This is consistent with the assumption that i) cyt-c release leads to a 3 
complete re-equilibration between the mitochondrial inter-membrane space (10% of mitochondrial 4 
volume) and the cytosol, and ii) that the volume fraction of mitochondria in cancer cells is low (5% was 5 
assumed), consistent with previous measurements by our group using z-stack confocal imaging and 6 
TMRM as a mitochondrial marker in several cell lines 29-31. In the second scenario a more modest 7 
depletion of cyt-c with 5% cyt-c remaining in the inter-membrane space was investigated. This depletion 8 
modelled incomplete cyt-c release due to impaired mitochondrial cristae remodelling 
32-34
, leaving a 9 
higher amount of cyt-c in the inter-membrane space. Alternatively, this situation resembled a situation 10 
where cells, such as cardiac muscle cells, have higher fractions of mitochondria (20%) resulting in higher 11 
cyt-c levels after re-equilibration between the mitochondrial inter membrane space and the cytosol 12 
compared to cells with a lower mitochondrial fraction. 13 
The model code was implemented in MATLAB (The Mathworks, UK) and is provided as supplementary 14 
text 2. 15 
Model Structure 16 
In an attempt to simplify the model layout, we defined model parameters, fluxes, components and state 17 
variables in a hierarchical manner. The lowest level of regulation was given by model parameters (Table 18 
III). These parameters defined the bioenergetic fluxes (Table II) which were grouped into model 19 
components (Table II, first column & Fig. 2, 1)-11)). As parameters are mathematically related to the 20 
fluxes defining these components, the influence of each parameter on these components is also defined, 21 
and is listed in Table III (2
nd
 column). Text colour coding in Fig. 2 also indicates whether parameter 22 
increases lead to an increase or decrease in component activity. In certain cases, one parameter influenced 23 
two components and, conveniently, the direction of influence of this parameter on both components was 24 
always the same. Additionally, several parameters can influence the same component, as seen in Fig. 2. 25 
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Finally, bioenergetic state variables are influenced by defined fluxes (Table I). The bioenergetic state is 1 
defined as the entire set of bioenergetic state variables of Table I and quantified as below (Eq. 3). 2 
 3 
Extracting regulation principles of intact and impaired mitochondria 4 
Two methods were used to extract regulation principles of cellular bioenergetics from the mechanistic 5 
details of the model. Both methods studied how variations of the 31 parameters influenced either a 6 
bioenergetic state variable or the bioenergetic state as a whole. We assumed four biological situations in 7 
our analysis – 1) intact ATP producing mitochondria (ATP:ADP =3:1), 2) intact mitochondria under 8 
energy saturation (ATP:ADP =100:1), 3) impaired mitochondria following complete (99.5%) or 4) 9 
incomplete (95%) cytochrome-c release (the last two situations resulted in 70% and 67% ATP assuming 10 
the same ATP consumption as in 2) and considering mitochondrial impairment). 11 
In the first method (single parameter variation) each parameter was varied by a factor 10, 5, 0.2 or 0.1, 12 
equivalent to a ten- or five-fold up- or down-regulation. The fixed relationships between parameters and 13 
components allowed us to study how individual components influenced a bioenergetic state variable such 14 
as m (Table I).  15 
A second method (parameter cluster analysis) analysed the influence of multiple parameter changes on 16 
the entire bioenergetic state. This method aims to identify parameter combinations (‘clusters’) that have 17 
the greatest influence on the bioenergetic state. We therefore varied parameters in combinations, assessed 18 
the influence of these parameters on the bioenergetic state, performed a principal component analysis of 19 
the resulting data matrix, selected the most important principal components and grouped parameters 20 
within each component according to their origin (whether they come from respiration complexes and 21 
metabolites, ATP production, cytosolic ATP processes or from other sources). 22 
This method is an adaptation of the sloppy parameter analysis of 
35
 who studied co-variation of model 23 
parameters and the effect of these variations on model output. We assumed the bioenergetic state to be 24 
represented by a state vector    ji psps 00 

 that comprised all modelled bioenergetic state variables at 25 
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equilibrium conditions given in Table I. This state vector was calculated by a set of model parameters1 
jpp
00 

 and changes of state variables is  were investigated when model parameters changed from a 2 
reference scenario 0p

 to a scenario characterised by parameter vector p

. This change is quantified by 3 
defining the least square function  4 
2
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Taking into account that = 0 and noting that the positive definiteness of leads to a 13 
vanishing first derivative, the second derivative remains the leading term. We therefore analysed the 14 
Hessian matrix with components 15 
 
ji
ji
pp
p
H



022 
          Equation 5 16 
with respect to changes of the model parameters pi. To consider relative parameter changes, we replaced 17 
by the logarithmic derivatives and defined the normalised state variable      0/ pspsps iii

 . 18 
Inserting Eq. 1 into Eq. 3, we obtained 19 
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which is the outer product of the two logarithmic derivatives of the normalised state vector  psi

 1 
evaluated at 0p

. Since we evaluated 
ji
H  at 
0p

, the second derivatives vanished 
35
. The Hessian matrix 2 
(Eq. 3) was evaluated numerically via finite differences derivatives. The principal component analysis of 3 
Eq. 6 was performed using the MATLAB routine pcacov.  4 
 5 
6 
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Results 1 
 2 
A structured approach to the investigation of bioenergetic regulation in intact and impaired 3 
mitochondria 4 
To study cellular and mitochondrial bioenergetics under physiological and pathological conditions, we 5 
built upon a model proposed by Beard 
16
 that is partly based on earlier work by Korzeniewski 
16, 36-39
. 6 
Their model investigated ion and metabolite changes in three compartments; the mitochondrial matrix, 7 
the mitochondrial inter membrane space and the cytosol. It allowed us to study the influence of these 8 
changes on the mitochondrial membrane potential, m; a key parameter of mitochondrial bioenergetics. 9 
We previously adapted this model and calibrated it so that its bioenergetic state variables (Table I) 10 
resembled mitochondrial bioenergetics in HeLa cervical cancer cells 
17
. As input, the model assumed that 11 
the mitochondrial tricarbonic acid (TCA) cycle generated NADH/NAD disequilibrium (Fig. 2, component 12 
1). This disequilibrium established a redox flux that drove electron transfer and proton flux through 13 
respiratory complexes I, III and IV (components 2, 3, 4). The proton gradient then coupled to ATP 14 
production (component 5), adenosine nucleotide transferase (component 6) and ionic fluxes (components 15 
7-10). Cytosolic ATP turnover (component 11) was also modelled so that this component, together with 16 
mitochondrial ATP production, established a constant ratio of cytosolic ATP:ADP. This ratio was set to 17 
100:1 for cells under energy saturation or 3:1 for cells with high ATP consumption whose mitochondria 18 
need to produce ATP. The bioenergetic state variables and their changes over time, the bioenergetic 19 
fluxes that mediate these changes, the model parameters, the constants and ion concentrations, and the 20 
biophysical constraints are given in Tables I-V, respectively. 21 
To extract regulation principles for intact and impaired mitochondria we followed two parameter 22 
variation approaches where we aimed to identify regulatory components of mitochondrial bioenergetics 23 
(see method sections for details). In the first approach, we utilised single parameter variation to identify 24 
model components most influential in regulating bioenergetic state variables. In the second approach, we 25 
used a new method (parameter cluster analysis) to identify how model components cooperate in 26 
12 
 
(primarily) independent clusters to influence the entire bioenergetic state. In both approaches we checked 1 
whether variation of a certain parameter or combination of parameters severely changed bioenergetic state 2 
variables, such as the mitochondrial membrane potential (m), and analysed these changes in different 3 
scenarios (high/low ATP, intact or impaired mitochondria).  If parameter variations changed the model 4 
output, we concluded that model components or combinations of components associated with these 5 
parameters were decisive regulators of bioenergetics under these conditions.  6 
 7 
Respiratory complex I as a driver for establishing m in intact mitochondria 8 
We first analysed HeLa cells with intact mitochondria in two states; cells where cytosolic ATP 9 
consumption was low (cytosolic ATP:ADP ratio assumed as 100:1, denoted as state-4 mitochondria), and 10 
cells with high ATP consumption (ATP:ADP ratio assumed as 100:1, denoted as state-3 mitochondria) 11 
where mitochondria need to replenish ATP 
2, 9
. To study the influence of parameter variation on m in 12 
both cases, we varied each parameter independently by a 10- or 5-fold increase or decrease. Varying 13 
parameters in the state-4 scenario, we found that changes in total NADH concentration (parameter #1 in 14 
Table III, hash marks ‘#’ refer to parameters in Table III in further), total ubiquinone concentration (#3), 15 
complex I activity (#9), proton leak activity (#21), and the kinetic constant that defines the amount of 16 
cytosolic ATP consumption (#16) exercised the most significant influence on the mitochondrial 17 
membrane potential, m (Fig. 3A). Of note, the three most influential parameters were either 18 
metabolites associated with respiratory complex I or parameters that determined its enzymatic activity 19 
(Table II, component 2).  Since neither complex III nor complex IV activity, nor cytochrome-c (cyt-c) 20 
levels (the metabolite that transfers electrons between these complexes) were found to influence m, we 21 
concluded that complex I was the major component within the respiratory chain that regulated m in 22 
state-4 mitochondria. These results were further validated when we identified parameters associated with 23 
complex I, but not complex III or IV as being essential for regulating respiratory flux and the protomotive 24 
force in state-4 mitochondria (supplementary Figs. 1 (A) and 2 (A)). 25 
13 
 
The same decisive role for complex I-associated parameters was found when cells were assumed to have 1 
high ATP consumption and mitochondrial ATP production was only able to establish a lower ATP:ADP 2 
ratio of 3:1 (75% ATP) (state-3 respiration, Fig. 3B). In this scenario, however, adenosine nucleotide 3 
transferase (ANT, #19, as provider of mitochondrial ADP) replaced proton leak activity as a critical 4 
driver of m regulation. Several other interesting findings were obtained from studying this state-3 5 
scenario. First, we found that, while ANT had a decisive role in establishing m, the influence of ATP 6 
synthase activity was much smaller. Consistent with these observations, ANT activity, but not the activity 7 
of the ATP synthase enzyme, regulated ATP synthase flux (supplementary Fig. 3). These findings portray 8 
ATP synthase as a component that is driven by ANT (supplementary Fig. 4 and supplementary text for a 9 
discussion of ATP synthase as a “passive component”). Secondly as shown in Fig. 3B, m was quite 10 
robust against changes in the amount of cytosolic ATP consumption in state-3 mitochondria. This 11 
robustness is in agreement with experimental evidence demonstrating that even changes from state-3 to 12 
state-4 only modestly influence m (Nicholls and Budd, 2000) and is also in agreement with the notion 13 
that m, as a key regulator of ionic homeostasis, is robust against physiological changes in ATP 14 
consumption.   15 
Finally, as an important model validation, our model was stable to mild changes in the input parameters 16 
(#5-#8) in state-3 and state-4 mitochondria (Fig. 3A, B). This is consistent with the design decision to 17 
assume the TCA cycle as non rate-limiting; a decision made to confine our analysis to the study of the 18 
electron transport chain and its regulators (see Fig. 2). 19 
20 
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Regulation of m in impaired mitochondria 1 
Impaired mitochondrial function is a hallmark of several diseases such as cancer or Parkinson’s disease 2 
and a condition often induced by chemotherapeutic treatment 
8, 10, 40
. Likewise, hypoxia, which is present 3 
in many cancers, causes mitochondrial impairment due to the lack of adequate oxygen levels. We were 4 
therefore interested in applying our single parameter variation approach to the study of changes in cellular 5 
bioenergetics before and after mitochondrial impairment. Mitochondrial bioenergetics during hypoxia has 6 
previously been investigated 
41
. We focussed here on mitochondrial impairment in HeLa cells due to 7 
depletion of mitochondrial cytochrome-c. Cyt-c release and its subsequent depletion from the 8 
mitochondrial inter-membrane space are induced by chemotherapeutic drugs and an understanding of the 9 
bioenergetic consequences of cyt-c depletion is important to obtain better insights into the mechanisms of 10 
chemoresistance and clinical relapse.   11 
We assumed two cases of mitochondria depleted of cyt-c due to chemotherapeutic drugs. In the first case 12 
we assumed 0.5% remnant cyt-c available for respiration, mimicking complete cyt-c release and re-13 
equilibration of cyt-c levels in all compartments. In the second case we modelled 5% remnant cyt-c, 14 
assuming incomplete cyt-c release or a high volume fraction of mitochondria in the cell (see methods). 15 
We assumed state-3 conditions with the same ATP consumption as before (ATP:ADP = 3:1). However, 16 
impairment of mitochondrial ATP production due to cyt-c depletion (while maintaining the same 17 
cytosolic ATP consumption as in the state-3 scenario of Fig. 3B) led to lower levels of ATP (67% and 18 
70%, respectively). In both scenarios, parameters associated with complex III activity (#10, #11) 19 
significantly influenced m while complex I (#9) and complex IV (#13) activity were less important 20 
(Fig. 4A, B). This indicates that complex III is the major bottleneck in the respiratory chain when cyt-c is 21 
depleted. As the only striking difference between both scenarios, our results suggest that in the case of 22 
higher cyt-c depletion (to 0.5% remnant levels), proton leak activity (#21) exercised the most influence on 23 
m. This is consistent with the assumption that respiration, and therefore proton extrusion, is very low 24 
in such a case and any proton loss due to proton leaks severely impacts the proton gradient, and therefore 25 
15 
 
m.  In contrast, ANT activity (#19) was a more decisive regulator of m when cyt-c depletion was 1 
more modest (5%) suggesting that ATP production (with ANT as its major driver, see above) is still 2 
present in this case and influences m by proton consumption. 3 
 4 
The bioenergetic state of intact, ATP-producing mitochondria is regulated by three parameter 5 
clusters 6 
In the previous paragraphs, we demonstrated that by studying variations of ODE model parameters we 7 
can obtain regulatory principles in healthy (state-3 and state-4) and impaired (state-3 only) mitochondria. 8 
We next focussed on the entire set of bioenergetic state variables (Table I), which we denoted as the 9 
‘bioenergetic state’ as defined in the methods section. We investigated how this state is regulated by the 10 
interplay of several ODE model components such as the activities of respiration complexes, the levels of 11 
respiration metabolites, and ATP production and consumption.  12 
We therefore performed a pair-wise variation of model parameters and subsequently carried out a 13 
principal component analysis to identify what parameter combinations (and therefore ODE model 14 
components) act together to most significantly influence the bioenergetic state. We then focussed on the 15 
three parameter combinations (denoted as parameter clusters in further) that exercised the most significant 16 
influence (Fig. 5A). For further insight, parameters were grouped depending on whether they originated 17 
from an ODE component that describes 1) respiratory complexes and metabolites, 2) ATP consumption, 18 
3) ATP production or 4) other components of the model (Fig 5B). The method is described as ‘parameter 19 
cluster analysis’ in the methods section. 20 
This procedure allowed us to obtain a more abstract view of mitochondrial bioenergetics as a set of 21 
coherent, sufficiently separate, yet interacting entities. A similar way of portraying mitochondrial 22 
bioenergetics has been provided by top-down control analysis, assuming that abstract metabolic blocks, 23 
interacting via key intermediaries, control the bioenergetic state 
12-15
. These metabolic blocks and 24 
intermediaries are biologically motivated ad-hoc assumptions, however, and it is desirable to justify these 25 
16 
 
assumptions from a more mechanistic point of view. We therefore investigated whether the parameter 1 
clusters identified by our bottom-up approach were in agreement with the metabolic blocks and key 2 
intermediaries from top-down control analysis, and whether these clusters were maintained when ATP 3 
levels were significantly changed. 4 
As seen in Fig. 5, three parameter clusters exercised 87% control over the bioenergetic state variability 5 
for intact, ATP-producing (state-3) mitochondria (ATP:ADP = 3:1). Cluster 1 was responsible for 60% of 6 
this regulation. Besides a small contribution from the adenosine nucleotide transferase (ANT) activity 7 
parameter (#19), this cluster primarily included contributions from respiratory complexes I and III (#9, 8 
#10, #11) and their metabolites (NADH, cyt-c, ubiquinone; #1, #2, #3). Due to this high contribution 9 
from respiration-associated model components (90%, see pie chart Fig 5 (B)), we denoted cluster 1 as the 10 
“respiration” cluster. Of note, this cluster was similar to the metabolic block ‘oxidation subsystem’ used 11 
in top-down control analysis literature 
12, 14
. Cluster 2 accounted for 17% of the regulation. Parameters 12 
describing cytosolic ATP consumption accounted for 65% of this cluster (Fig 5B) while parameters 13 
related to mitochondrial ATP production such as total adenosine phosphate levels (#4), and ANT activity 14 
(#19) accounted for a further 30%. We therefore denoted cluster 2 as the “ATP production/consumption” 15 
cluster. It can be compared to a combination of the two metabolic blocks ‘phosphorylation subsystem’ 16 
and ‘ATP consumption’ used in top-down control analyses. Cluster 3 accounted for 10% of the regulation 17 
and included important parameters of clusters 1 and 2. We denoted cluster 3 the “respiration-ATP 18 
production coupler” cluster. This cluster did not resemble a metabolic block from top-down control 19 
analyses. Rather, it coupled the metabolic blocks ‘oxidation subsystem’ and ‘phosphorylation subsystem’ 20 
and can be viewed as a key intermediary within the context of top-down control analyses. 21 
Bioenergetic clusters in intact mitochondria under energy saturation  22 
Some top-down control analyses assume metabolic blocks as static over a broad range of bioenergetic 23 
scenarios which is regarded as an important limitation in their applicability 
42, 43
. We therefore 24 
investigated whether the same parameter clusters were present when studying mitochondria under energy 25 
17 
 
saturation. In particular, we were interested in whether a similar coupling pattern between respiration and 1 
ATP production, as in Fig. 5, was present when intact mitochondria under energy saturation were 2 
considered. Thus, we repeated our parameter cluster analysis for intact mitochondria in state-4 (ATP:ADP 3 
= 100:1), where very little ATP production is assumed to occur. These energy conditions are equivalent to 4 
those in mitochondria of HeLa cells in full nutrient medium 
26
. 5 
As before, three major clusters were identified that exercised 85% control over the bioenergetic state (Fig. 6 
6A). Cluster 1 was retained as an almost wholly “respiration” cluster with major contributions from 7 
respiratory complex metabolites (#1-3) and respiratory complex parameters (#9-12). Clusters 2 and 3, 8 
however, no longer clearly separated into “ATP production/consumption” and “respiration-ATP-9 
production coupler”, as cluster 2 now also had a significant, 25% influence from parameters associated 10 
with metabolites or respiratory complexes. The lack of a separate cluster that described ATP production 11 
and consumption may be due to the fact that in HeLa cells with high ATP levels, ATP consumption is 12 
low, the turnover between ATP production and consumption is modest and therefore the contribution to 13 
the regulation of bioenergetics is low. Since an independent ATP production cluster was not identified, 14 
the assumption of a model where an independent respiration cluster interacts with an independent ATP 15 
production cluster cannot be assumed in the case of intact, energy saturated mitochondria. 16 
Different parameter clustering in impaired mitochondria 17 
Finally, we investigated the regulation of the bioenergetic state for impaired mitochondria after cyt-c 18 
release to 5% remnant cyt-c. We assumed state-3 conditions with the same cytosolic ATP consumption as 19 
before which, as mitochondrial ATP production was impaired due to depleted cyt-c, led to cytosolic ATP 20 
levels of 67% (not shown in figure). Similar to intact mitochondria, three parameter clusters exercised 21 
significant control (77%) over the bioenergetic state (Fig. 7A). Importantly, however, all three major 22 
clusters were influenced by distinct model parameters suggesting that each cluster regulated the 23 
bioenergetic state independently from the others. In addition, two major clusters were influenced by 24 
respiratory components and metabolites (Fig. 7B). The first cluster had 50 % influence on the 25 
18 
 
bioenergetic state and included mostly complex III activity and complex III associated metabolites, 1 
consistent with the decisive role of complex III after cyt-c release. Strikingly, while complex I activity did 2 
not have any influence in any of the three clusters, its driving metabolite (NADH) almost completely 3 
influenced cluster 2 (11% influence on the bioenergetic state). Finally, cluster 3 consisted of ATP 4 
production and consumption and this cluster exercised 16% influence on the bioenergetic state. In 5 
conclusion, these results indicate that complex I activity is uncoupled from the activity of the other 6 
respiratory complexes and respiration is largely uncoupled from ATP production/consumption, 7 
suggesting a lack of interplay between bioenergetic components after cyt-c release.  8 
 9 
Discussion  10 
In this study, we have devised an approach to extract control principles of mitochondrial and cellular 11 
bioenergetics from mechanistically detailed, ODE based models by analysing how bioenergetic state 12 
variables (Table I) changed with model parameter (Table III) variation. Studying intact mitochondria 13 
(ATP-producing and non-ATP-producing) by varying model parameters independently from each other, 14 
our model identified respiratory complex I and its metabolites, NAD/NADH and ubiquinone, as key 15 
regulators of m. Respiratory complexes III and IV did not show any detectable influence on m in 16 
this scenario, even when their activity was increased or decreased ten-fold. This suggests that complex I 17 
is the most critical regulator within the mitochondrial electron transport chain in intact mitochondria. 18 
Indeed, complex I has been identified as rate-limiting for respiration in primary neuron synaptosomes 
44
, 19 
and complex I inhibition led to more severe respiration impairment than complex III inhibition in primary 20 
neurons 
45-48
. Due to this rate-limiting action, respiratory complex I deregulation is a hallmark of various 21 
pathologies. To this end, post-mortem analysis of the substantia nigra from patients suffering from 22 
Parkinson’s disease showed complex I impairment in 25%–30% of the patients 10. Likewise, the K-Ras 23 
oncoprotein that is mutated in 50% of all colorectal carcinomas was found to lead to complex I 24 
19 
 
impairment and reduction of mitochondrial respiration 
40
. Reduced mitochondrial respiration in favour of 1 
elevated glycolyisis is a well known characteristic of many cancers.  2 
 3 
In impaired mitochondria depleted of cyt-c, however, our model predicted complex III activity as rate-4 
limiting for respiration. This is consistent with a previous study by our group 
49
 where complex III was 5 
identified as the major site of reactive oxygen species (ROS) production (as a measure of respiration 6 
impairment) in hippocampal neurons subsequent to cyt-c release.  7 
 8 
Lower oxygen levels may also work synergistically with a more modest impairment of complex III 9 
activity, and lead to a similar rate limiting role for complex III 
41
. Hypoxic conditions are typical for many 10 
cancers while complex III impairment is present after chemotherapeutically induced cyt-c release 
28
. It is 11 
therefore reasonable to assume that cancer cells that survive chemotherapeutic treatment are both low in 12 
oxygen and have impaired complex III. They may therefore be critically sensitive to further changes in 13 
complex III activity.  14 
 15 
Top-down metabolic control analysis (MCA) is used to study cellular bioenergetics by defining metabolic 16 
blocks linked by key intermediaries
12, 50
. Here, we have developed a complementary, bottom-up approach 17 
to study how metabolites, ions and fluxes influence mitochondrial bioenergetics. As output, our method 18 
predicted how model parameters act in combinations (denoted as clusters) to perturb the bioenergetic 19 
state. Assuming intact, ATP-producing mitochondria (ATP:ADP = 3:1), we found three parameter 20 
clusters that controlled 89% of the bioenergetic state. These clusters – “respiration”, “ATP 21 
production/consumption” and “respiration-ATP-production coupler” - can be associated to metabolic 22 
blocks or coupling components of metabolic blocks assumed by MCA. The identified “respiration 23 
cluster” (cluster 1) is equivalent to the MCA component ‘respiration subsystem’, while the identified 24 
“respiration-ATP-production coupler” (cluster 3) is assumed to be a coupling component (‘key 25 
intermediary’ in an MCA context) between respiration and mitochondrial ATP production. Of note, 26 
20 
 
cluster 2 described a composition of two MCA components, mitochondrial ATP production and cytosolic 1 
ATP consumption. The fact that our approach predicted two MCA components, ATP production and 2 
consumption, within one cluster (intra-cluster coupling) while ATP production and respiration coupled 3 
via a separate cluster (inter-cluster coupling) suggests that ATP production couples tighter to ATP 4 
consumption (via ATP levels) than to respiration (via the protomotive force). This may, however, be 5 
reflected in the structure of the analysed ODE model, where we assumed a simplistic process of cytosolic 6 
ATP consumption that is only dependent on ATP levels. In contrast, coupling of ATP production to 7 
respiration via the protomotive force was modelled in a more complex way (where all respiratory 8 
complexes and proton leaks influenced the protomotive force).  9 
Importantly, the composition of all three clusters changed when ATP was close to 100% (ATP:ADP = 10 
100:1). Moreover, when mitochondria were depleted of cytochrome-c (cyt-c) no coupling of the major 11 
clusters was observed. In this instance, ATP production only poorly coupled with respiration (10% 12 
contribution to first cluster). In addition, two separate respiratory clusters were identified in cyt-c depleted 13 
mitochondria; one with a major influence on the bioenergetic state, driven by complex III parameters, and 14 
one with a minor influence on the bioenergetic state, driven by the complex I metabolite NADH. In 15 
summary, these results suggest that in top-down control analyses, static metabolic blocks should not be 16 
assumed during significant ATP level changes or in situations where mitochondria change from 17 
physiological to pathological conditions such as during cyt-c release.  18 
 19 
Models that integrate metabolism and signalling are essential to understanding how metabolic fluxes are 20 
redirected by signalling events or by oncoproteins, and how tumour suppression and cell death machinery 21 
prevent cells from metabolic and oncogenic transformations 3, 4, 51. Oncogenic alterations in metabolism, 22 
however, are often the result of several oncoproteins or deregulations of metabolic enzymes 
6, 7, 52, 53
. 23 
Consequently, the interlocking network of metabolism and signalling is large and intricate. Given the 24 
high degree of unknown kinetic parameters and protein concentrations needed for model construction, 25 
analyses with mechanistic ODE models alone are impractical. A more abstract method, therefore, is 26 
21 
 
needed to elucidate the principles of how aberrant signalling alters metabolism. While top-down control 1 
analysis provides an excellent level of abstraction, we have shown that the assumption of static metabolic 2 
blocks may not always be justified. Moreover, while top-down control analysis is well suited to studying 3 
quasi-static metabolic fluxes, cellular signal transduction such as activation of cell death proteases has 4 
been shown to be highly dynamic 
54, 55
.  Our method described herein combines the mechanistic details of 5 
ODE based models with the potential to extract higher level metabolic regulation principles. It is 6 
therefore well suited to analysing the interplay of metabolic, oncogenic and cell death signalling in larger 7 
scale networks. In conclusion, our study advocates for this bottom-up analysis as an important 8 
complement to top-down control analyses when studying larger networks describing the interplay of 9 
signalling and metabolism, and provides a missing link between high-level top-down analyses and 10 
mechanistically detailed approaches. 11 
 12 
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Tables  1 
Table I: Bioenergetic state variables, their initial values and temporal changes used in the ODE 2 
model: The first and second columns provide the symbol and description of the bioenergetic state 3 
variables employed in the ODE model. The third column gives the initial concentration used in the 4 
calculations. The fourth column describes their temporal changes based on bioenergetic fluxes (Table II) 5 
and on parameters in Tables IV and V. These temporal changes constitute the ODE system. Indices x, i 6 
and c of state variables and metabolites indicate mitochondrial matrix, inter-membrane space and cytosol, 7 
respectively.    8 
Symbol Description Initial conc.  [mM] 
ODE equation 
Temporal change : d [symbol] / dt = … 
Hx Matrix protons 10
-5
 (pH=8) 
 xbuff *  Hx * ( JDH – (4+1)*JC1 – (4-2)*JC3 –  
 (2+2)*JC4 + (nA–1)*JF1 + 2*JPi1 + JHle – JKH ) / Wx 
Kx Matrix potassium 50 (JKH + JK) / Wx 
Mg
2+
x Matrix magnesium 1 ( – JMgATPx – JMgADPx ) / Wx 
NADH2
 
x Matrix NADH 1.5 (+JDH – JC1) / Wx 
QH2
2
x Matrix ubiquinone 0.8 (JC1– JC3) / Wx 
cytCox Oxidised cyt-c (IMS) 1.5 (2 JC3– 2JC4) / Wi 
cytCred Reduced cyt-c (IMS) 1.2 calculated from total cyt-c 
ATP x Matrix free ATP 3:1 or 100:1 (+ JF1 – JANT) / Wx 
ADP x Matrix free ADP 1:3 or 1:100 (- JF1 + JANT) / Wx 
ATP mx Matrix Mg
2+
-bound ATP 0 ( JMgATPx) / Wx 
ADP mx Matrix Mg
2+
-bound ADP 0 (JMgADPx) / Wx 
Pi x 
Matrix phosphate 
(Phosphate ions) 
10 
(– JF1 + JPiHt ) / Wx 
ATP i IMS free ATP 0 (+ JATP + JANT + JAKi ) / Wi 
ADP i IMS free ADP 0 (+ JADP – JANT – 2*JAKi ) / Wi 
ATP mi IMS Mg
2+
-bound ATP 0 (JMgATPi) / Wi 
ADP mi IMS Mg
2+
-bound ADP 0 (JMgADPi) / Wi 
Pi i IMS phosphate 
(Phosphate ions) 
10 
(– JPiHt + JPi2 ) / Wi 
m 
Mitochondrial Membrane  
potential 
150 ( 4*JC1 + 2*JC3 + 4*JC4 – nA*JF1 – JANT  
– JHle  – JK ) / Cim 
Hi IMS protons 
10
-5
 (pH=8) (– JDH + (4+1)*JC1 + (4-2)*JC3 + (2+2)*JC4  
– (nA–1)*JF1 – 2*JPi1 – JHle + JKH + JHt) / Wi 
ATP c Cytosolic ATP 3:1 or 100:1 (-JATP - JATPC)/ Wc 
ADP c Cytosolic ADP 1:3 or 1:100 (-JADP + JATPC)/ Wc 
 9 
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Table II: Model components and their bioenergetic fluxes in the ODE’s: Mathematical forms of the 1 
bioenergetic fluxes that mediate state variable changes in Table I. The first column contains model 2 
component numbers assigned to bioenergetic fluxes (components numbered in Fig. 2). The second column 3 
describes the flux and the flux symbol used in Table I. The third column contains the mathematical formula 4 
defining the flux. Fluxes depend on state variables (Table I), model parameters (Table III) and biophysical 5 
constraints (Table IV). All flux biophysical details can be found in 
16
. 6 
 7 
# Flux Flux equation for ODE (Table 1) 
1) Input flux NAD 
(Dehydrogenase flux) 
JDH     = XDH * (r x * NADx – NADHx) * { (1+Pi x/ kPi1) / (1+Pix / kPi2) } 
2) Respiratory complex I JC1     = XC1 * ( exp (– ( dGC1op+4*dGH) / RT ) * NADHx * Q – NADx * QH2) 
3) Respiratory complex III JC3    = XC3 * ((1+Pix / kPi3 ) / (1+Pix / kPi4 ) ) *{exp (– (dGC3op 
+4* dGH2* F *m) / (2*RT)) *Cox *QH2 
0.5
 – cytC red*Q 
0.5
} 
4) Respiratory complex IV 
 
JC4     
 
= XC4*(O2,x / (O2,x +kO2 ) ) * (cytC red / cytC tot )*{exp( – ( dGC4op+2* dGH)  
/ (2*RT)) *  cytC red  * (O2,x
0.25
) – cytC ox *exp ( F*m / RT ) } 
5) ATP synthase (FoF1) J F1     = XF1*(exp(– ( dGF1op–nA* dGH ) /RT ) * (KDD /KDT ) * ADPmx *Pix – ATPmx 
5) Binding of Mg
2+
 to 
matrix ATP 
JMgATPx  = XMgA * (ATPfx * Mgx  – KDT * ATPmx) 
5) Binding of Mg
2+
 to inner 
membrane ATP 
JMgATPi   = XMgA* (ATPfi  * Mgi  – KDT*ATPmi) 
5) Binding of Mg
2+
 to 
matrix ADP 
JMgADPx  = XMgA*(ADPfx * Mgx  – KDD*ADPmx) 
5) Binding of Mg
2+
 to inner 
membrane ADP 
JMgADPi  = XMgA*(ADPfi * Mgi  – KDD*ADPmi) 
6) Adenosine nucleotide 
transferase (ANT) 
JANT  
 
= xANT* ( ADPfi  / (ADPfi +ATPfi * exp(–F*i /RT)) –  
ADPfx  / (ADPfx+ATPfx * exp(–F*x /RT)) )*(ADPfi/(ADPfi+kmADP)) 
7) Proton leaks JHle    = XHle * m *(Hi *exp( F * m / RT)–Hx ) / (exp( F * m / RT)–1) 
8) ADP MOM permeability JADP  = *XA * ( ADPc – ADPi) 
8) ATP MOM permeability JATP  = *XA * ( ATPc – ATPi) 
8) phosphate MOM 
permeability 
JPi2  
 
= * XPi2 * ( Pic– Pii ) 
8) proton MOM 
permeability 
JHt = * XHT *( Hi – Hx ) 
9) Phosphate/proton JPi1    = XPi1 * (Hx * H2PIi – Hi * H2PIx ) / (H2PIi+ kdHPi ) 
10) Potassium/hydrogen JKH = XKH * ( Ki * Hx – Kx * Hi ) 
11) Cytosolic ATP processes JATPC = xATPK * (ATPe- KADTP *ADPe) 
 




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Table III: Model parameters used in the ODE’s, their influence on model components and their 1 
standard values 2 
Model parameters are listed whose variations are discussed in the paper. The first column provides the 3 
parameter reference number that was used throughout the text and figures. The second column refers to 4 
component numbers, given in Table II and Figure 1, and whether the component is positively (+) or 5 
negatively (-) influenced by this parameter (direct or indirect proportional relation of the parameter to the 6 
component as seen from Table II). The name, description, value and units of the parameters are also given. 7 
Values were taken from 1) 
21
,  2) 
2
, 3) 
29
, 4) 
17
, 5) fitted to match ATP:ADP ratio of 3:1 (state 3), 6) fitted to 8 
match ATP:ADP ratio of 100:1 (state 4).  9 
*) KATPK is assumed to be lower than the actual ATP:ADP ratio leading to cytosolic consumption of ATP. 10 
The lower KATPK, the higher the consumption 11 
n.a.) These model parameters are not associated to a component, but are general parameters used in the 12 
model. 13 
 # Regulates Symbol Name used in the text (explanation) Value Units 
1 +2) NADtot Total NAD(H) 0.242 
3)
  mM 
2 +3), +4) cytC tot    Total cyt–c. 2.7 
1)
 mM 
3 +2), +3) Q Total ubiquinone 1.35 
1)
 mM 
4 +4), +5) Atot Total adenosine phosphate (ATP+ADP+AMP)  4.86 
4)
 mM 
5 -1) kPi,1 Input 1 (phosphate dependency) 0.13413 
1) 
mM 
6 -1) kPi,2 Input 2 (phosphate dependency) 0.67668 
1) 
 mM 
7 +1) XDH Input 3 (flux activity) 0.09183 
 1)
 mol s
–1
 M
–1 
(l mito vol)
 –1
 
8 +1) r  Input 4 (NADH/NAD ratio) 45.807  
4)
 Unitless 
9 +2) XC1 Complex I activity 1.02 * 10
+3   4)
 mol s
–1
 M
–1 
(l mito vol)
 –1
 
10 +3) XC3 Complex III activity 0.2241 
4)
 mol s
–1
 M
–1 
(l mito vol)
 –1
 
11 -3) kPi,3 Complex III parameter 1 (phosphate dependency) 0.19172 
1)
   mM 
12 -3) kPi,4 Complex III parameter 2 (phosphate dependency) 25.31 
1)
 mM 
13 +4) XC4 Complex IV activity 3.2 * 10
–4   4)
 mol s
–1
 M
–1 
(l mito vol)
 –1
 
14 +4) kO2 Complex IV  parameter  (oxygen saturation) 1.2 * 10
–4   4)
 M 
15 +5) XF1 ATP Synthase activity 6.83 * 10
+3   4)
 
 
mol s
–1
 M
–2 
(l mito vol)
 –1
 
16 +11)
 *)
 xATPK 
 
ATP consumption kinetics  
 
1.1
  5)
, 0.0540
6)
 min
–1
 
17 - 11) 
*)
 KATPK ATP consumption equilibrium ATP:ADP 
 
2 
5)
, 30 
6)
 Unitless 
18 +5), +6) XMgA Mg
2+
 concentration 20
   2)
 mM 
19 +6) XANT ANT activity 2  * 10
–3   1)
 
1)
 
mol s
–1
 (l mito vol)
 –1
 
20 +6) km,ADP ANT parameter 1 (Michaelis-Menten) 3.5 * 10
–6   2)
 M 
21 +7) XHle Proton leak activity 150 
1)
 mol s
-1
 M
-1 
(l mito vol)
 -1
 
22 +8) XHt 
 
Mito outer membrane (MOM) proton permeability 
 
20 
1)
 m s–1 
25 
 
1 
23 +8)  Mito outer membrane (MOM) area  5.99 
1)
 m–1 
24 +8) XA 
 
Mito outer membrane (MOM)  nucleotide 
permeability 
 
327. 
1)
 m s–1 
25 +8) XPi2 
 
Mito outer membrane  (MOM) phosphate 
permeability to  
 
85. 
1)
 m s–1 
26 -9) kdHPi H
+ 
/ Phos parameter 1 (proton-phosphate binding) 
 
1* 10
–6.75   1)
 M 
27 -9) kPIH H
+ 
/ Phos par. 2 (proton –phosphate dissociation) 
constant 
4.5 * 10
–4   1)
 M 
28 +9) XPi1 H
+ 
/ Phos  activity 3.3943 * 10
+5   
 mol s
–1
 M
–1 
(l mito vol)
 –1
 
29 +10) XKH K
+ 
/ H 
+
 activity
 
 (Potassium-proton antiport)
 
  2.9802 * 10
+7   
1)
 
mol s
-1
 M
-2 
(l mito vol)
 -1
 
30 n.a. Xbuff Matrix hydrogen buffer  100 
1)
 M
–1
 
31 n.a. Cim Mito capacitance 6.76 * 10
–6   1)
 mol
–1
 (l mito vol)
 –1
mV  
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Table IV: Constants and ion concentrations for the fluxes in Table I  1 
Constants and ion concentrations used in the model and taken from 1) 
21
,  2) 
2
, 3) 
29
  2 
Symbol Description Value Unit 
F Faraday constant 0.096484 kJ
–1
 mol
–1
 mV
–1
 
T Absolute temperature 310.15 (37) K (
o 
C) 
R Universal gas constant 8314 * 10
–6   
 
 
kJ
–1
 mol
–1
 K
–1
 
nA Protons 
 
pumped in by ATP Synthase 3 
1)
 Unitless 
Mgtot Total cytosolic concentration of Mg
2+
   20 
2)
 mM 
Pitot Total cytosolic concentration of phosphate   20 
2)
 mM 
Ktot Ionic conc. of potassium in the cytosol 120 
2)
 mM 
pHc Cytosolic pH 7.4 Unitless 
dGC1o 
 
Gibbs Energy for Complex I/II  –69.37 1) kJ mol–1 
dGC3o 
 
Gibbs Energy for Complex III –32.53 1) kJ mol–1 
dGC4o 
 
Gibbs Energy for Complex IV –122.94 1) kJ mol–1 
dGF1o 
 
Gibbs Energy for ATP Synthase  36.03 
1)
 
 
kJ mol
–1 
O2x Oxygen concentration matrix 2.6* 10
–5   1)
 M 
Wx Volume fraction matrix/Total mito 0.9 
1)
 Unitless 
Wi Volume fraction IMS/Total mito 0.1 
1)
 Unitless 
Wc Volume fraction cytosol/mitochondria 20 
3)
 Unitless 
 3 
4 
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Table V: Biophysical constraints for fluxes in Table I: Biophysical constraints that result from moiety 1 
or chemical conservation as used in the model. Indices x, i and c of metabolites and chemical compounds 2 
indicate mitochondrial matrix, inter-membrane space and cytosol, respectively. Indices mx, mi and mc 3 
indicate magnesium bound ATP and ADP while mf, mi and mc indicate free ATP and ADP in the 4 
mitochondrial matrix, inter-membrane space and cytosol, respectively. The index tot refers to the total 5 
moiety of a metabolite, while red and ox indicate reduced and oxidised from of cyt-c. 6 
 
Moiety conservation 
NADx 
(NADi) 
= NADtot – NADHx  (NADHi) 
 
Qx (Qi) 
 
 
= Qtot   – QH2x   (QH2i) 
 
 
cytC ox 
 
= cytC tot   – cytC red 
 Conservation of Mg–bound ADP/ATP 
ATPfx   
 
= ATPx – ATPmx 
 ADPfx 
 
= ADPx – ADPmx 
 ATPfi 
 
= ATPi – ATPmi 
ADPfi 
 
= ADPi – ADPmi 
 ADPmc 
 
= ½ * [(KDD + ADPc + Mgtot) –   
{ ( KDD+ADP c +Mgtot ) 
2–4*(ADPt* 
ADPc ) }
1/2
] 
 ADPfc 
 
= ADPc – ADPmc 
 Mgc = Mgtot  – ADPm 
 Gibbs energies of complexes 
dGH  
 
= F*m + RT * Ln ( Hi  / Hx  ) 
 dGC1op 
 
= dGC1o –  RT * Ln (Hx  /10
–7 
) 
 dGC3op 
 
= dGC3o + 2*RT * Ln (Hx  /10
–7 
) 
 dGC4op 
 
= dGC4o – 2*RT * Ln ( Hx  /10
–7 
) 
 dGF1op 
 
=  dGF1o –  RT * Ln ( Hx / 10
–7 
) 
 
   
 
Phosphate–Hydrogen binding 
H2PIi = Pii * Hi / (Hi + kdHPi)  
 
 
H2PIx  = Pix* Hx / (Hx + kdHPi) 
 Parameter for ANT 
x

= – 0.65*m 
 i

= + 0.35*m 
 Values for cyt–c after release 
CytCrelease = cytC tot   / 200 (0.5%)  
cytC tot   / 20  (5 %) 
Gibbs energies synthase 
dGH  
 
= F*m + RT * Ln ( Hi  / Hx  ) 
 dGC1op 
 
= dGC1o –  RT * Ln (Hx  /10
–7 
) 
 dGC3op 
 
= dGC3o + 2*RT * Ln (Hx  /10
–7 
) 
 dGC4op 
 
= dGC4o – 2*RT * Ln ( Hx  /10
–7 
) 
 dGF1op 
 
=  dGF1o –  RT * Ln ( Hx / 10
–7 
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Figure legends 1 
Figure 1: Study design and key findings 2 
The strategy followed to identify bioenergetic regulation principles in HeLa cells under different 3 
conditions is depicted and key findings of this study are highlighted. Building on the recently calibrated 4 
bioenergetic ODE model of Beard 
16, 17
, we utilised two different methods of parameter variation to 5 
extract regulatory principles of cellular bioenergetics. Both methods were applied to cells with intact 6 
state-3 and state-4 mitochondria (‘physiological conditions’) and to cells whose mitochondria were 7 
depleted of cytochrome-c (cyt-c). The respective figures where results are discussed are also highlighted 8 
(MCA – Metabolic Control Analysis). 9 
Figure 2: The bioenergetic model, model components and model parameters 10 
Illustration of the model used to study mitochondrial bioenergetics. The model incorporated components 11 
of the cytosol, the mitochondrial inter-membrane space (IMS) and the mitochondrial matrix. Model 12 
components are denoted with Arabic numbers and associated to bioenergetic fluxes in Table II: 1) Input 13 
flux from TCA cycle (see methods); 2) -4) respiratory complexes I, III and IV, respectively; 5) ATP 14 
synthase; 6) adenosine nucleotide transferase (ANT); 7) proton leaks; 8) outer membrane ATP/ADP and 15 
phosphate (Pi) passive transporters; 9) proton (H+)/phosphate co-transport; 10) potassium(K+) /proton 16 
antiport; 11) cytosolic ATP processes consisting of cytosolic ATP production and consumption. 17 
Parameters associated with model components are listed below the component and denoted by hash 18 
marks (‘#’) according to Table III. Parameters that influence two components are written below these 19 
components. The influence of parameters on model components is defined in Table III. Grey 20 
regular/black italic text refers to model parameters that increase/decrease the activity of the associated 21 
component(s). When one parameter influenced two model components, the influence was in the same 22 
direction. 23 
 24 
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Figure 3: Drivers of the mitochondrial membrane potential (m) in resting and ATP-producing 1 
mitochondria 2 
Single parameter variation of model parameters was performed as described and the influence on the 3 
mitochondrial membrane potential, m, is given for (A) resting (state-4, ATP:ADP = 100:1) and (B) 4 
ATP-producing (state-3, ATP:ADP = 3:1) mitochondria. Dark blue, light blue, green, orange and brown 5 
bars refer to a tenfold decrease, fivefold decrease, reference value, fivefold increase and tenfold increase 6 
of model parameters, respectively. Parameters are ranked according to their influence on m with 7 
lowest rank indicating highest influence. In both situations, complex I was identified as the most 8 
important respiratory complex in determining m. This is indicated by the low ranking of the parameter 9 
describing complex I activity (#9) and parameters describing the concentration of its metabolites (NADH 10 
(#1), ubiquinone (#3)). Hash marks (‘#’) denote parameters according to Table III. Further results are 11 
discussed in the text. 12 
 13 
Figure 4: Single parameter variation analysis subsequent to cytochrome-c release 14 
Single parameter variation of model parameters was performed as described in the case of complete (A) 15 
and incomplete (B) cytochrome-c (cyt-c) release (0.5% or 5% remnant cyt-c, respectively). Hash marks 16 
(‘#’) denote parameters according to Table III. The influence on the mitochondrial membrane potential, 17 
m, was evaluated and parameters were ranked according to their influence. Respiratory complex III 18 
activity (#10) and parameters (#11, #12) and total cyt-c concentration (#2) were major regulators of m, 19 
indicating a shift from respiratory complex I to respiratory complex III as a major regulator of respiration 20 
and m following cyt-c release. Dark blue, light blue, green, orange and brown bars refer to a tenfold 21 
decrease, fivefold decrease, reference value, fivefold increase and tenfold increase of model parameters, 22 
respectively. Further results are discussed in the text. 23 
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 1 
Figure 5: The bioenergetic state of cells with intact, ATP producing mitochondria (ATP:ADP = 3:1, 2 
state-3) is regulated by three parameter clusters that resemble clusters assumed by top-down 3 
control analyses  4 
Results from parameter cluster analysis as described in the text for HeLa cells with intact mitochondria 5 
and an ATP:ADP ratio of 3:1 (state 3). Model parameters are indicated by hash mark numbers according 6 
to Table III. A principal component analysis and subsequent parameter grouping were performed. (A) 7 
Principal component analysis identified three principal components that exercised 87% control over the 8 
bioenergetic state. The colour bar indicates the relative contribution of each parameter to the respective 9 
principal component (parameter loadings). Parameters contributing significantly to each principal 10 
component (loading > 0.2) are outlined in black. The total percentage influence of these outlined 11 
parameters on the respective principal component is given. (B) Parameters were assigned to groups as 12 
indicated by colour coding ‘Respiratory complex metabolites & parameters’ (blue), ’ATP consumption’ 13 
(red), ‘ATP production’ (orange) and ’Input & proton leaks & others’ (brown). For each principal 14 
component in (A) the collective influence of each parameter group is given in the pie chart. In this way 15 
categorised principal components were denoted as clusters. Respiratory complex metabolites and 16 
parameters primarily regulated cluster 1 (“respiration” cluster), parameters influencing ATP production 17 
and consumption primarily regulated cluster 2 (“ATP-production/consumption” cluster), and a mixture of 18 
“respiratory complex metabolites & parameters” and “ATP production/consumption” regulated cluster 3 19 
(“Respiration-ATP coupler” cluster).  20 
 21 
22 
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Figure 6: The bioenergetic state in cells with intact, resting state mitochondria (ATP:ADP = 100:1, 1 
state-4) does not lead to a decoupling of ATP production in a separate cluster  2 
Results from parameter cluster analysis as described in the text for HeLa cells with intact, resting 3 
mitochondria and an ATP:ADP ratio of 100:1 (State 4). Model parameters are indicated by hash mark 4 
numbers according to Table III. As described for Fig. 5, a principal component analysis was performed 5 
(A) and parameters were assigned to groups (B). Three parameter clusters exercised 85 % control over the 6 
bioenergetic state. As above (Fig 5), cluster 1 was primarily composed of mitochondrial respiration 7 
parameters and cluster 3 coupled mitochondrial respiration to mitochondrial ATP production. However, 8 
mitochondrial and cytosolic ATP processes were not clearly decoupled from mitochondrial respiration in 9 
cluster 2. 10 
 11 
Figure 7: The bioenergetic state in impaired mitochondria subsequent to cyt-c release  12 
Results from parameter cluster analysis as described in Fig 5, consisting of a principal component 13 
analysis (A) and parameter grouping (B) for impaired mitochondria following cyt-c release (5% remnant 14 
cyt-c and 70% ATP (ATP:ADP less than 3:1 due to respiration impairment)). Parameters are indexed by 15 
hash mark numbers according to Table III and grouped as described in Fig.5B. Although three parameter 16 
clusters exercised 77% control over the bioenergetic state, parameter clustering changed in comparison to 17 
intact mitochondria (Fig. 5). Cluster 1 remained primarily a respiration cluster, yet did not include total 18 
NADH levels (#1). In turn, cluster 2 was mainly driven by NADH levels (95% of cluster) and to a minor 19 
extent by total ubiquinone levels (3%). Cluster 3 described mitochondrial ATP production and cytosolic 20 
ATP consumption processes. Strikingly, negligible coupling of parameter clusters was observed. 21 
 22 
23 
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